CompRe gets regulatory green light for MedMal deal

Compre, the Bermuda headquartered international legacy group, has received regulatory approval to acquire the French medical malpractice portfolio from a European based insurer for an undisclosed sum.

The deal, structured as a loss portfolio transfer to be followed by a legal transfer, supports Compre’s ambition to build a centre of excellence for MedMal in Europe.

The portfolio contains legacy, live and prospective risks through 2023. The transaction was brokered by Guy Carpenter.

Simon Hawkins, chief executive Europe said: “I am delighted to announce our second acquisition of European MedMal legacy liabilities. We worked closely with the insurer to ensure the structure optimises capital release and provides operational finality. This transaction further demonstrates our client-focused approach, which ensured our client’s objectives were realised, and our commitment to building a centre of excellence for MedMal in Europe.”